lotemax ey.dro.sus 0,5% w/v (5mg/1ml)
olympus ΕΜΠΟΡΙΑ ΙΑΤΡΙΚΩΝ ΕΙΔΩΝ ΜΟΝΟΠΡΟΣΩΠΗ ΙΔΙΩΤΙΚΗ ΚΕΦΑΛΑΙΟΥΧΙΚΗ ΕΤΑΙΡΕΙΑ Δ.Τ. olympus Λήμνου 5 & Θάσου, 142 35 Ν. Ιωνία 210.2821721 & 2711714 - loteprednol etabonate - ey.dro.sus (ΟΦΘΑΛΜΙΚΕΣ ΣΤΑΓΟΝΕΣ, ΕΝΑΙΩΡΗΜΑ) - 0,5% w/v (5mg/1ml) - loteprednol etabonate 5mg - loteprednol
lotemax 0.5% eye drops
dr.gerhard mann chem.-pharm. fabrik gmbh (0000003416) brunsbutteler damm 165/173, berlin, 13581 - loteprednol etabonate - eye drops - 0.5% - loteprednol etabonate (8000002355) 5mg - loteprednol etabonate
elymbus® eye.gel 0.1mg/g in single-dose container
bimatoprost - eye.gel (ΟΦΘΑΛΜΙΚΗ ΓΕΛΗ) - 0.1mg/g in single-dose container - bimatoprost 0,1mg - bimatoprost
evorel 50mcg/24h transdermal patch
janssen-cilag international nv (0000003494) turnhoutseweg, 30, beerse, b-2340 - estradiol - transdermal patch - 50mcg/24h - estradiol (0000050282) 3.2mg - estradiol
zovirax 5% w/w cream
glaxosmithkline (ireland) limited (0000010774) 12 riverwalk, citywest business campus, dublin, dublin 24 - aciclovir - cream - 5% w/w - aciclovir (0059277893) 50mg - aciclovir
volibris
glaxosmithkline (ireland) limited - ambrisentan - Υπέρταση, πνευμονική - Αντιυπερτασικά, - volibris is indicated for treatment of pulmonary arterial hypertension (pah) in adult patients of who functional class (fc) ii to iii, including use in combination treatment (see section 5. efficacy has been shown in idiopathic pah (ipah) and in pah associated with connective tissue disease. volibris is indicated for treatment of pah in adolescents and children (aged 8 to less than 18 years) of who functional class (fc) ii to iii including use in combination treatment. efficacy has been shown in ipah, familial, corrected congenital and in pah associated with connective tissue disease (see section 5.
fenobrat caps 160mg/cap
bausch health ireland limited, ireland 3013 lake drive, d24ppt3 dublin 24 - fenofibrate - caps (ΚΑΨΑΚΙΟ, ΣΚΛΗΡΟ) - 160mg/cap - fenofibrate 160mg - fenofibrate